VAERS reports by lot

Merck HPV lot 1425F: VAERS reports

43 VAERS reports list lot 1425F as a Merck HPV vaccine, received between 2007-01-23 and 2016-09-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
63%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2316%
General / Systemic (non-local)2316%
Injection-site / Local reaction1813%
Musculoskeletal1611%
Cardiac / Cardiovascular1511%
Dermatological (non-injection-site)128%
Allergic / Anaphylactic107%
Respiratory96%
Gastrointestinal96%
Reproductive / Menstrual43%
Psychiatric / Neuropsychiatric32%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
South Dakota4
New Jersey4
Illinois4
Michigan3
New Hampshire3
Pennsylvania2
California2
Delaware1
Massachusetts1
Washington1
Florida1

Reports by month received

2007-013
2007-026
2007-036
2007-048
2007-057
2007-071
2007-084
2007-091
2007-111
2007-121
2008-011
2008-072
2008-111
2016-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.